Boston Therapeutics, Inc. Contracts & Agreements

105 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Nanomix Corporation Chief Financial Officer Employment Offer Letter with Christopher R. Hetterly
Employment Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2023
Securities Purchase Agreement between Nanomix Corporation and Purchasers dated October 21, 2022
Subscription Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2022
Nanomix Corporation CEO Employment Offer Letter to Thomas Schlumpberger (July 21, 2022)
Employment Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2022
Consent, Amendment and Waiver Agreement between Nanomix Corporation and HT Investments MA LLC (March 22, 2022)
Waiver Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2022
Consent, Amendment and Waiver Agreement between Nanomix Corporation and HT Investments MA LLC (February 24, 2022)
Waiver Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2022
Certificate of Designation for Series B Convertible Preferred Stock of Boston Therapeutics, Inc.
Articles of Amendment
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2021
Exchange Agreement between Boston Therapeutics, Inc. and Holder for Securities-for-Shares Transaction
Exchange Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Debt Settlement and Release Agreement between Boston Therapeutics, Inc. and Creditor
Release Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Unwind Agreement between Boston Therapeutics, Inc., CureDM, Inc., and CureDM Group Holdings, LLC (August 6, 2019)
Release Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2019
Contribution Agreement between Boston Therapeutics, Inc., CureDM Group Holdings, LLC, and CureDM Members (January 1, 2018)
Contribution Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2018
Executive Retention Agreement between Boston Therapeutics, Inc. and Loraine Upham
Retention Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
MA
2018
Certificate of Designation of Series A Convertible Preferred Stock of Boston Therapeutics, Inc.
Articles of Amendment
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2017
Executive Employment Agreement between Carl W. Rausch and Boston Therapeutics, Inc.
Employment Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
MA
2016
Boston Therapeutics, Inc. Subscription Agreement for Common Stock and Warrants
Subscription Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2015
Marketing Agreement between Boston Therapeutics, Inc. and Benchworks SD LLC (May 14, 2014)
Marketing Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2014
Separation Agreement and General Release between Kenneth A. Tassey, Jr. and Boston Therapeutics Inc.
Separation Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NH
2014
Boston Therapeutics, Inc. Common Stock Subscription Agreement with Investor
Subscription Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2013
Employment Agreement between Boston Therapeutics, Inc. and Ken Tassey (President and COO)
Employment Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
MA
2013
Boston Therapeutics, Inc. Chief Operating Officer Employment and Stock Option Agreement with Jonathan B. Rome
Employment Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2012
Boston Therapeutics, Inc. Subscription Agreement with Investor for Common Stock Purchase
Subscription Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2012
Employment Agreement between Boston Therapeutics, Inc. and Ken Tassey (President and COO)
Employment Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
MA
2012
License and Manufacturing Agreement between Boston Therapeutics, Inc. and Advance Pharmaceutical Company Limited
License Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2011
Employment Agreement between Boston Therapeutics, Inc. and Ken Tassey (President and COO)
Employment Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
MA
2011
Boston Therapeutics, Inc. Subscription Agreement with Investor for Common Stock Purchase
Subscription Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
MA
2011
Description of Nanomix Corporation Securities Registered Under Section 12 of the Exchange Act
Stock Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2023
Nanomix, Inc. Warrant to Purchase Common Stock (Assumed in Merger)
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
CA
2022
Description of Securities Registered Under Section 12 of the Exchange Act – Nanomix Corporation
Stock Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2022
Development and License Agreement between RedPharm (Beijing) Biotechnology Co., Ltd., Medical Technology Associates II, Inc., and Nanomix, Inc. dated September 26, 2017
License Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
CA
2022
First Amendment to Development and License Agreement among RedPharm (Beijing) Biotechnology Co., Ltd., Medical Technology Associates II, Inc., and Nanomix, Inc.
License Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2022
Common Stock Purchase Warrant Agreement between Nanomix Corporation and GHS Investments, LLC (March 23, 2022)
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2022
Securities Purchase Agreement between NanoMix Corporation and Purchaser (March 2022)
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2022
Nanomix Corporation Senior Secured Convertible Note, Issued February 25, 2022
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2022
Nanomix Corporation Warrant to Purchase Common Stock, Dated February 25, 2022
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2022
Nanomix Corporation Securities Purchase Agreement with Investors (February 25, 2022)
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2022
Boston Therapeutics, Inc. Senior Secured Convertible Note dated June 25, 2021
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Boston Therapeutics, Inc. Warrant to Purchase Common Stock, Dated June 25, 2021
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Securities Purchase Agreement between Boston Therapeutics, Inc. and Investors (June 25, 2021)
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Registration Rights Agreement between Boston Therapeutics, Inc. and Buyers (June 25, 2021)
Registration Rights Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Security and Pledge Agreement between Boston Therapeutics, Inc., Subsidiaries, and HT Investments MA LLC (Collateral Agent) dated June 25, 2021
Security Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Guaranty Agreement by Boston Therapeutics, Inc. Subsidiaries in Favor of HT Investments MA LLC (June 25, 2021)
Guaranty Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Exchange Agreement between Boston Therapeutics, Inc. and Holder for Convertible Promissory Notes (June 2021)
Exchange Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Secured Promissory Note between Boston Therapeutics, Inc. and Gold Blaze Limited (April 30, 2021)
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Nanomix, Inc. 10% Secured Promissory Note to Boston Therapeutics, Inc. (April 30, 2021)
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Agreement and Plan of Merger among Boston Therapeutics, Inc., BTHE Acquisition Inc., and Nanomix, Inc. (February 2, 2021)
Merger Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2021
License Agreement between Level Brands, Inc. and Boston Therapeutics, Inc. for Use of kathy ireland Health & Wellness Trademark
License Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
CA
2018
Boston Therapeutics, Inc. $100,000 Promissory Note Dated June 12, 2018
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
MA
2018
Securities Purchase Agreement between Boston Therapeutics, Inc. and Purchasers (2017)
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2017
Common Stock Purchase Warrant Agreement between Boston Therapeutics, Inc. and Holder
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2017
Securities Purchase Agreement between Boston Therapeutics, Inc. and Purchaser
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2017
Boston Therapeutics, Inc. 6% Subordinated Convertible Debenture Due 2019
Debenture Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2017
Boston Therapeutics, Inc. Stock Purchase Warrant Agreement (April 2017)
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2017
Amendment to Executive Employment Agreement between Boston Therapeutics, Inc. and Carl W. Rausch
Modification Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2017
Boston Therapeutics, Inc. Securities Purchase Agreement with Purchasers
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2016
Boston Therapeutics, Inc. 6% Senior Convertible Debenture Due 2018
Debenture Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2016
Boston Therapeutics, Inc. Stock Purchase Warrant Agreement (June 2016)
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2016
Amendment to 10% Convertible Promissory Notes between Boston Therapeutics Inc. and CJY Holdings Limited
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2016
Amendment to Securities Purchase Agreement between Boston Therapeutics Inc. and CJY Holdings Limited
Modification Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2016
Amendment to Securities Purchase Agreement between Boston Therapeutics Inc. and CJY Holdings Limited
Modification Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2016
Amendment to Securities Purchase Agreement Between Boston Therapeutics Inc. and CJY Holdings Limited
Modification Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2016
Amendment to Securities Purchase Agreement Between Boston Therapeutics Inc. and CJY Holdings Limited
Modification Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2016
Amendment to Securities Purchase Agreement Between Boston Therapeutics Inc. and CJY Holdings Limited
Modification Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2015
Warrant Repricing and Exercise Agreement between Boston Therapeutics, Inc. and CJY Holdings Limited
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NH
2015
Amendment to Securities Purchase Agreement Between Boston Therapeutics Inc. and CJY Holdings Limited
Modification Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2015
Securities Purchase Agreement between Boston Therapeutics, Inc. and Buyer (September 24, 2015)
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NH
2015
Boston Therapeutics, Inc. 10% Convertible Promissory Note with CJY Holdings Limited (Due September 24, 2018)
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NH
2015
Debt Settlement and Warrant Cancellation Agreement between Boston Therapeutics, Inc. and Typenex Co-Investment, LLC
Release Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2015
Securities Purchase Agreement between Boston Therapeutics, Inc. and JDF Capital, Inc. dated March 13, 2015
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2015
Boston Therapeutics, Inc. 10% OID Convertible Promissory Note with JDF Capital Inc. (March 13, 2015)
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2015
$500,000 Convertible Note Agreement between Boston Therapeutics, Inc. and JMJ Financial
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
FL
2015
Securities Purchase Agreement between Boston Therapeutics, Inc. and Vis Vires Group, Inc. dated March 16, 2015
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2015
Convertible Promissory Note between Boston Therapeutics, Inc. and Vis Vires Group, Inc. dated March 16, 2015
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2015
Securities Purchase Agreement between Boston Therapeutics, Inc. and Typenex Co-Investment, LLC (March 12, 2015)
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
UT
2015
Convertible Promissory Note between Boston Therapeutics, Inc. and Typenex Co-Investment, LLC dated March 12, 2015
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
UT
2015
Warrant to Purchase Common Stock between Boston Therapeutics, Inc. and Typenex Co-Investment, LLC
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
UT
2015
Common Stock Purchase Warrant Agreement between Boston Therapeutics, Inc. and Holder
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2015
Common Stock Purchase Warrant Agreement between Boston Therapeutics, Inc. and Laidlaw & Company (UK) Ltd.
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2014
Common Stock Purchase Warrant Agreement between Boston Therapeutics, Inc. and Holder
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2013
Common Stock Purchase Warrant Agreement between Boston Therapeutics, Inc. and Holder
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2013
Technology Assignment Agreement between Avanyx Therapeutics, Inc. and David Platt
Assignment Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2013
Amended and Restated Boston Therapeutics, Inc. 2010 Stock Plan
Stock Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2013
Boston Therapeutics, Inc. Amended and Restated 2011 Non-Qualified Stock Plan
Stock Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2013
Promissory Note between Avanyx Therapeutics, Inc. and David Platt dated February 9, 2010
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
MA
2013
Agreement and Plan of Merger among Avanyx Therapeutics, Inc., Boston Therapeutics, Inc., and Ken Tassey
Merger Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2013
Certificate of Merger Between Boston Therapeutics, Inc. and Avanyx Therapeutics, Inc.
Merger Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2013
License and Manufacturing Agreement between Boston Therapeutics, Inc. and Advance Pharmaceutical Company Limited
License Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2013
Unit Purchase Agreement between Boston Therapeutics, Inc. and Purchasers (August 6, 2013)
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2013
Boston Therapeutics, Inc. Registration Rights Agreement with Investor (August 30, 2013)
Registration Rights Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2013
Common Stock Purchase Warrant Agreement between Boston Therapeutics, Inc. and Holder
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2013
Common Stock Purchase Warrant Agreement between Boston Therapeutics, Inc. and Holder
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2013
Amended and Restated Boston Therapeutics, Inc. 2010 Stock Plan
Stock Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2013
Unit Purchase Agreement between Boston Therapeutics, Inc. and Purchasers (August 6, 2013)
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2013
Boston Therapeutics, Inc. Registration Rights Agreement with Investor (August 30, 2013)
Registration Rights Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2013
Amended and Restated Boston Therapeutics, Inc. 2010 Stock Plan
Stock Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2013
Common Stock Purchase Warrant Agreement between Boston Therapeutics, Inc. and Holder (2012)
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2012
Technology Assignment Agreement between Avanyx Therapeutics, Inc. and David Platt
Assignment Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2012
Avanyx Therapeutics, Inc. 2010 Stock Incentive Plan
Stock Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2012
Boston Therapeutics, Inc. 2011 Non-Qualified Stock Plan
Stock Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2012
Promissory Note between Avanyx Therapeutics, Inc. and David Platt dated February 9, 2010
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
MA
2012
Agreement and Plan of Merger among Avanyx Therapeutics, Inc., Boston Therapeutics, Inc., and Ken Tassey
Merger Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2012
Certificate of Merger Between Boston Therapeutics, Inc. and Avanyx Therapeutics, Inc.
Merger Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2012
License and Manufacturing Agreement between Boston Therapeutics, Inc. and Advance Pharmaceutical Company Limited
License Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2012
Agreement and Plan of Merger among Avanyx Therapeutics, Inc., Boston Therapeutics, and Ken Tassey
Merger Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2010
Technology Assignment Agreement between Avanyx Therapeutics, Inc. and David Platt
Assignment Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2010
Avanyx Therapeutics, Inc. 2010 Stock Incentive Plan
Stock Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2010
Promissory Note between Avanyx Therapeutics, Inc. and David Platt dated February 9, 2010
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
MA
2010